Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings
- 2 November 2022
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 16 (11-12) , 1205-1212
Abstract
The value of treating asthma with the triple regimen of inhaled corticosteroid (ICS), long-acting β2-agonist (LABA), and long-acting muscarinic antagonist (LAMA) delivered using multiple inhalers (...Keywords
This publication has 43 references indexed in Scilit:
- Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma–COPD overlap syndrome consulting for routine careInternational Journal of Chronic Obstructive Pulmonary Disease, 2018
- Role of muscarinic antagonists in asthma therapyExpert Review of Respiratory Medicine, 2017
- Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic statusRespiratory Medicine, 2016
- Long-term Outcomes After Stepping Down Asthma Controller MedicationsChest, 2015
- Tiotropium may improve asthma symptoms and lung function in asthmatic patients with irreversible airway obstruction: the real‐life dataThe Clinical Respiratory Journal, 2014
- Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-AgonistsApplied Health Economics and Health Policy, 2014
- Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changesPulmonary Pharmacology & Therapeutics, 2013
- Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008Primary Care Respiratory Journal, 2011
- Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthmaClinical Therapeutics, 2008
- The long-acting beta-agonist controversy: A clinical dilemmaAllergy and Asthma Proceedings, 2007